A pair of entrepreneurial brothers who lost their bid to build a hotel in a massive four-storey commercial building next to ...

Vanda Pharmaceuticals stands at a pivotal point, leveraging strong Fanapt growth and a robust late-stage pipeline for future expansion. VNDA's aggressive investment in commercial infrastructure has ...

Overview: Vanda Pharmaceuticals Inc. is a biopharmaceutical company that develops and commercializes therapies for high unmet medical needs globally, with a market cap of approximately $303.76 million ...

Shares of Vanda Pharmaceuticals rose after a study evaluating its treatment to prevent side effects from weight-loss drug Wegovy met its primary endpoint. The stock climbed 18%, to $5.20, late Tuesday ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...